Angiotensin system inhibitors and survival in patients with metastatic renal cell carcinoma treated with VEGF targeted therapy: A pooled secondary analysis of clinical trials.
Research output: Contribution to journal › Article › peer-review
20Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Angiotensin system inhibitors and survival in patients with metastatic renal cell carcinoma treated with VEGF targeted therapy: A pooled secondary analysis of clinical trials.'. Together they form a unique fingerprint.